- In patients receiving acarbose, the use of orlistat without a prescription is not recommended due to the lack of studies on pharmacokinetic interactions (See Interactions)
This slowing contributes to the appetite suppression that drives weight loss and the postprandial glucose-lowering effect, and it also drives most of the gastrointestinal side effect profile.[1],[2] A 2025 review in the Journal of Clinical Endocrinology & Metabolism summarizes the published evidence: GLP-1 receptor agonists impact gastric, intestinal, and gallbladder motility simultaneously, with effects on gastric fundus relaxation, antral contractility inhibition, increased pyloric tone, and reduced small intestinal motility.[3] The path from this mechanism to constipation is straightforward
Full text: Barciela, P., Perez-Vazquez, A., & Prieto, M
In that sense, if 5-amino-1MQ had effects on the same molecular pathways as exercise, aged mice treated with the compound that also exercised would not receive much of an effect from the treatment
by source author(s): Zhang, Z., Wallace, M.B., Feng, J., Stafford, J.A., Kaldor, S.W., Shi, L., Skene, R.J., Aertgeerts, K., Lee, B., Jennings, A., Xu, R., Kassel, D., Webb, D.R., Gwaltney, S.L